Pijus K. Mandal

1.9k citations
31 papers · 1.3k indexed · h-index 20

Pijus K. Mandal

31 papers receiving 1.3k citations

Peers

Pijus K. Mandal
Comparison fields: 5 of 89
  • Oncology 514
  • Organic Chemistry 473
  • Toxicology 48
  • Immunology 214
  • Molecular Biology 585
Replace M. V. Ramana Reddy with:
M. V. Ramana Reddy United States
Stuart L. Emanuel United States
Gui‐Dong Zhu United States
Ji‐Wang Chern Taiwan
Jason G. Kettle United Kingdom
Lee D. Arnold United States
Ho H. Lee New Zealand
Ute Hoch United States
Yuanxiang Wang China
Hiroshi Kosugi Japan
Pijus K. Mandal relative to M. V. Ramana Reddy United States M. V. Ramana Reddy's profile →
Citations per field
00.5×
M. V. Ramana Reddy · 1×
Citations per year

Countries citing papers authored by Pijus K. Mandal

Since Specialization
Citations

This map shows the geographic impact of Pijus K. Mandal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pijus K. Mandal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pijus K. Mandal more than expected).

Fields of papers citing papers by Pijus K. Mandal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pijus K. Mandal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pijus K. Mandal. The network helps show where Pijus K. Mandal may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pijus K. Mandal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pijus K. Mandal Line = papers co-authored together Pijus K. Mandal links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201822
2 2017128
3 201457
4 201415
5 201321
6 201211
7
A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis.
201233
8 201221
9 201117
10 2011103
11 20093
12 20093
13 20093
14 200890
15 2007175
16 200626
17 200510
18 2005108
19 200167
20 199927

About Pijus K. Mandal

Pijus K. Mandal is a scholar working on Oncology, Organic Chemistry and Immunology, having authored 31 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (16 papers), Protein Tyrosine Phosphatases (10 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Chemical Synthesis and Analysis (6 papers), Oxidative Organic Chemistry Reactions (3 papers), interferon and immune responses (3 papers), Asymmetric Synthesis and Catalysis (3 papers) and Asymmetric Hydrogenation and Catalysis (3 papers). The work is most often cited by research in Oncology (514 citations), Organic Chemistry (473 citations) and Toxicology (48 citations). Pijus K. Mandal has collaborated with scholars based in United States, India and Netherlands. Frequent co-authors include John S. McMurray, Subhas Chandra Roy, Xiaohong Chen, Warren S.‐L. Liao, Zhiyong Ren, Gourhari Maiti, Robert C. Bast, Fengqin Gao, Zhen Lü and Chiyi Xiong. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026